Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 2016, Article ID 5914048, 5 pages
http://dx.doi.org/10.1155/2016/5914048
Research Article

Comparison of One versus Two Fecal Immunochemical Tests in the Detection of Colorectal Neoplasia in a Population-Based Colorectal Cancer Screening Program

1Division of Gastroenterology & Hepatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada
2British Columbia Cancer Agency, Colon Screening Program, Hereditary Cancer Program, University of British Columbia, Vancouver, BC, Canada

Received 28 March 2016; Accepted 18 October 2016

Academic Editor: Michael Beyak

Copyright © 2016 Sarvenaz Moosavi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Canadian Cancer Statistics, Canadian Cancer Society, Toronto, Canada, 2015.
  2. P. Hewitson, P. Glasziou, E. Watson, B. Towler, and L. Irwig, “Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update,” The American Journal of Gastroenterology, vol. 103, no. 6, pp. 1541–1549, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Tang, W. J. Boscardin, I. Stijacic-Cenzer, and S. J. Lee, “Time to benefit for colorectal cancer screening: survival meta-analysis of flexible sigmoidoscopy trials,” British Medical Journal, vol. 350, Article ID h1662, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Levin, D. A. Lieberman, B. McFarland et al., “Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology,” Gastroenterology, vol. 134, no. 5, pp. 1570–1595, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. D. K. Rex, D. A. Johnson, J. C. Anderson et al., “American College of Gastroenterology guidelines for colorectal cancer screening 2009,” The American Journal of Gastroenterology, vol. 104, no. 3, pp. 739–750, 2009. View at Publisher · View at Google Scholar
  6. D. Leddin, R. Hunt, M. Champion et al., “Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: Guidelines on colon cancer screening,” Canadian Journal of Gastroenterology, vol. 18, no. 2, pp. 93–99, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. R. E. Davila, E. Rajan, and T. H. Baron, “ASGE guideline: colorectal cancer screening and surveillance,” Gastrointestinal Endoscopy, vol. 63, no. 4, pp. 546–557, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. J. J. Y. Sung, S. C. Ng, F. K. L. Chan et al., “An updated Asia Pacific Consensus Recommendations on colorectal cancer screening,” Gut, vol. 64, no. 1, pp. 121–132, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. C. M. Bacchus, L. Dunfield, S. Connor Gorber et al., “Recommendations on screening for colorectal cancer in primary care,” Canadian Medical Association Journal, vol. 188, no. 5, pp. 340–348, 2016. View at Google Scholar
  10. M. Pignone and H. C. Sox, “Screening guidelines for colorectal cancer: a twice-told tale,” Annals of Internal Medicine, vol. 149, no. 9, pp. 680–682, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. L. G. van Rossum, A. F. van Rijn, R. J. Laheij et al., “Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population,” Gastroenterology, vol. 135, no. 1, pp. 82–90, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Hol, M. E. Van Leerdam, M. Van Ballegooijen et al., “Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy,” Gut, vol. 59, no. 1, pp. 62–68, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Quintero, A. Castells, L. Bujanda et al., “Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening,” The New England Journal of Medicine, vol. 366, no. 8, pp. 697–706, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. J. J. Telford, A. R. Levy, J. C. Sambrook, D. Zou, and R. A. Enns, “The cost-effectiveness of screening for colorectal cancer,” Canadian Medical Association Journal, vol. 182, no. 12, pp. 1307–1313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. J. Heitman, R. J. Hilsden, F. Au, S. Dowden, and B. J. Manns, “Colorectal cancer screening for average-risk North Americans: an economic evaluation,” PLoS Medicine, vol. 7, no. 11, Article ID e1000370, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. G. P. Young, D. J. St John, S. J. Winawer, and P. Rozen, “Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report,” The American Journal of Gastroenterology, vol. 97, no. 10, pp. 2499–2507, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. A. H. C. van Roon, J. A. Wilschut, L. Hol et al., “Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance,” Clinical Gastroenterology and Hepatology, vol. 9, no. 4, pp. 333–339, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. C. S. Wong, J. Y. L. Ching, V. C. W. Chan et al., “Diagnostic accuracy of a qualitative fecal immunochemical test varies with location of neoplasia but not number of specimens,” Clinical Gastroenterology and Hepatology, vol. 13, no. 8, pp. 1472–1479, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. A. S. Kosinski, “A weighted generalized score statistic for comparison of predictive values of diagnostic tests,” Statistics in Medicine, vol. 32, no. 6, pp. 964–977, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. J. K. Lee, E. G. Liles, S. Bent, T. R. Levin, and D. A. Corley, “Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis,” Annals of Internal Medicine, vol. 160, no. 3, pp. 171–181, 2014. View at Google Scholar · View at Scopus
  21. L. Guittet, V. Bouvier, N. Mariotte et al., “Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location,” British Journal of Cancer, vol. 100, no. 8, pp. 1230–1235, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. T.-H. Chiang, S.-L. Chuang, S. L.-S. Chen et al., “Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program,” Gastroenterology, vol. 147, no. 6, pp. 1317–1326, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. L. F. Brown and C. G. Fraser, “Effect of delay in sampling on haemoglobin determined by faecal immunochemical tests,” Annals of Clinical Biochemistry, vol. 45, no. 6, pp. 604–605, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. M. Lane, E. Chow, G. P. Young et al., “Interval fecal immunochemical testing in a colonoscopic surveillance program speeds detection of colorectal neoplasia,” Gastroenterology, vol. 139, no. 6, pp. 1918–1926, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Guittet, V. Bouvier, N. Mariotte et al., “Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples,” International Journal of Cancer, vol. 125, no. 5, pp. 1127–1133, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Nakama, M. Yamamoto, N. Kamijo et al., “Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia,” Hepato-Gastroenterology, vol. 46, no. 25, pp. 228–231, 1999. View at Google Scholar · View at Scopus
  27. D. I. Park, S. Ryu, Y.-H. Kim et al., “Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening,” The American Journal of Gastroenterology, vol. 105, no. 9, pp. 2017–2025, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Hernandez, J. Cubiella, M. C. Gonzalez-Mao et al., “Fecal immunochemical test accuracy in average-risk colorectal cancer screening,” World Journal of Gastroenterology, vol. 20, no. 4, pp. 1038–1047, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. D. A. Lieberman, D. K. Rex, S. J. Winawer, F. M. Giardiello, D. A. Johnson, and T. R. Levin, “Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer,” Gastroenterology, vol. 143, no. 3, pp. 844–857, 2012. View at Publisher · View at Google Scholar · View at Scopus